XML 43 R27.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stock-Based Awards | 12 Months Ended
--- | ---
Jan. 29, 2022
Share-based Payment Arrangement [Abstract] |
Stock-Based Awards | Stock-Based Awards We have outstanding stock-based awards under our 2003 Long-Term Incentive Plan, 2007 Non-Employee Directors Equity Plan, 2012 Long-Term Incentive Plan, and 2017 Non-Employee Directors Equity Plan (collectively, the “Plans”). No further awards will be granted under the 2003 Long-Term Incentive Plan or 2007 Non-Employee Directors Equity Plan. As of January 29, 2022, the total number of shares available for grant under the Plans was 639,569. Stock-based compensation expense and the related tax benefit recognized during fiscal 2022, fiscal 2021, and fiscal 2020 were as follows (dollars in thousands):
| Fiscal Year Ended |
| January 29, 2022 |  | January 30, 2021 |  | January 25, 2020 |
Stock-based compensation | $ | 9,866 |  |  | $ | 12,771 |  |  | $ | 10,034 |  |
Income tax effect of stock-based compensation | $ | 2,435 |  |  | $ | 3,141 |  |  | $ | 2,482 |  |
In addition, we realized approximately $2.9 million of net excess tax benefits during fiscal 2022, and $0.5 million of net excess tax benefits during fiscal 2021. We realized $1.0 million of net tax deficiencies in fiscal 2020, related to the vesting and exercise of share-based awards. As of January 29, 2022, we had unrecognized compensation expense related to stock options, RSUs, and target Performance RSUs (based on the Company’s expected achievement of performance measures) of $2.0 million, $13.6 million, and $8.3 million, respectively. This expense will be recognized over a weighted-average number of years of 2.6, 2.4, and 2.1, respectively, based on the average remaining service periods for the awards. As of January 29, 2022, we may recognize an additional $7.3 million in compensation expense in future periods if the maximum number of Performance RSUs is earned based on certain performance measures being met. The following table summarizes the valuation of stock options and restricted share units granted during fiscal 2022, fiscal 2021, and fiscal 2020, and the significant valuation assumptions:
| Fiscal Year Ended |
| January 29, 2022 |  | January 30, 2021 |  | January 25, 2020 |
Weighted average fair value of RSUs granted | $ | 82.25 |  |  | $ | 27.75 |  |  | $ | 48.37 |  |
Weighted average fair value of Performance RSUs granted | $ | 84.73 |  |  | $ | 25.15 |  |  | $ | 45.94 |  |
Weighted average fair value of stock options granted | $ | 52.33 |  |  | $ | 14.63 |  |  | $ | 24.72 |  |
Stock option assumptions: |  |  |  |  |  |
Risk-free interest rate | 1.6 | % |  | 0.7 | % |  | 2.3 | % |
Expected life (in years) | 9.3 |  | 9.4 |  | 8.4 |
Expected volatility | 53.4 | % |  | 51.3 | % |  | 45.3 | % |
Expected dividends | — |  |  | — |  |  | — |  |
Stock Options The following table summarizes stock option award activity during fiscal 2022:
| Stock Options
| Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (In years) |  | Aggregate Intrinsic Value (In thousands)
Outstanding as of January 30, 2021 | 344,963 |  |  | $ | 49.66 |  |  |  |  |
Granted | 29,738 |  |  | $ | 85.02 |  |  |  |  |
Options exercised | (42,580) |  |  | $ | 53.10 |  |  |  |  |
Canceled | — |  |  | $ | — |  |  |  |  |
Outstanding as of January 29, 2022 | 332,121 |  |  | $ | 52.39 |  |  | 5.4 |  | $ | 11,321 |
Exercisable options as of January 29, 2022 | 230,762 |  |  | $ | 53.28 |  |  | 4.2 |  | $ | 7,744 |
The total amount of exercisable options as of January 29, 2022 presented above reflects the approximate amount of options expected to vest. The aggregate intrinsic values presented above represent the total pre-tax intrinsic values (the difference between the Company’s closing stock price of $84.53 on the last trading day of fiscal 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last trading day of fiscal 2022. The amount of aggregate intrinsic value will change based on the price of the Company’s common stock. The total intrinsic value of stock options exercised was $1.9 million, $8.1 million, and $1.8 million for fiscal 2022, fiscal 2021, and fiscal 2020, respectively. We received cash from the exercise of stock options of $2.3 million, $5.7 million, and $0.5 million during fiscal 2022, fiscal 2021, and fiscal 2020, respectively. RSUs and Performance RSUs The following table summarizes RSU and Performance RSU award activity during fiscal 2022:
| Restricted Stock
| RSUs |  | Performance RSUs
| Share Units |  | Weighted Average Grant Price |  | Share Units |  | Weighted Average Grant Price
Outstanding as of January 30, 2021 | 648,361 |  |  | $ | 33.29 |  |  | 425,344 |  |  | $ | 54.03 |
Granted | 77,109 |  |  | $ | 82.25 |  |  | 273,858 |  |  | $ | 84.73 |
Share units vested | (190,254) |  |  | $ | 39.01 |  |  | (70,890) |  |  | $ | 57.59 |
Forfeited or canceled | (10,961) |  |  | $ | 35.26 |  |  | (172,512) |  |  | $ | 62.07 |
Outstanding as of January 29, 2022 | 524,255 |  |  | $ | 38.49 |  |  | 455,800 |  |  | $ | 68.88 |
The total number of granted Performance RSUs presented above consists of 188,883 target shares and 84,975 supplemental shares. During fiscal 2022, we canceled 88,057 target shares and 74,024 supplemental shares of Performance RSUs, as a result of performance criteria for attaining those shares being partially met for the applicable performance periods. Approximately 163,831 target shares and 79,093 supplemental shares outstanding as of January 29, 2022 will be canceled during the three months ending April 30, 2022 as a result of the fiscal 2022 performance period criteria being partially met. The total amount of Performance RSUs outstanding as of January 29, 2022 consists of 303,555 target shares and 152,245 supplemental shares. The total fair value of restricted share units vested during fiscal 2022, fiscal 2021, and fiscal 2020 was $22.4 million, $3.1 million, and $6.7 million, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration